BMPR2 and pulmonary hypertension: Similarly, both carnitine metabolism and fatty acid oxidation are significantly depressed in human pulmonary vascular endothelial cells containing a bone morphogenetic protein receptor type 2 (BMPR2) mutation [32] again suggesting a link between carnitine metabolism and mitochondrial dysfunction in pulmonary hypertension.